Chris Crucitti

Chief Commercial Officer at Clinical Ink

Chris Crucitti is a 20+ year seasoned life sciences and clinical services/technology executive. As chief commercial officer (CCO), Chris supports the continued growth, optimizing go-to-market strategies and building a scalable customer service approach. Prior to joining Clinical Ink, Chris most recently held the role of CCO at Signant Health, leading commercial functions for their patient-centric clinical technology solutions. Chris brings significant experience and expertise in the clinical and R&D domains, including full-service CRO, data and analytics, eClinical technology solutions, strategic resourcing, consulting, and commercial. He has a track record of leading and building teams that drive significant revenue and profitability growth while maintaining a high level of customer service and quality delivery. Chris holds a master’s from American University and a bachelor’s from Ithaca College.


  • Chief Commercial Officer

    May, 2021 - present


By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.